Owned audience
The weekly peptide briefing
One concise email a week: the most important new studies, news, and data, each with its evidence tier, in plain language. No spam. Unsubscribe anytime.
Double opt-in · FTC & privacy compliant · 8,400+ readers · See our privacy policy
1
Evidence-tiered. Every item is rated, so you know how strong the science is.
2
Plain language. Written for real people, not just researchers.
3
Independent. No clinic affiliation, no hype, no funnels.